The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
|Videos|October 18, 2022
Expert: Pharmacists are Health Care Providers for Local Communities
As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is.
Advertisement
As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is. Ronna Hauser, PharmD, senior vice president of Policy and Pharmacy Affairs at the National Community Pharmacists Association, discusses how pharmacists can be advocates for their patients and simplify the health care system for them.
Ronna Hauser: The value of the pharmacist is a local provider of health care in their communities. Interestingly enough, this week, the National Association of Boards of Pharmacy just updated their Model Practice Act to include the term "health care practitioner" in the definition of a pharmacist and also to include enhance clinical services that pharmacist offer in their communities. Pharmacists are absolutely a trusted source and a health care provider within communities that have a very local connection with their patients.
Advertisement
Related to this article
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
Victoria P. Werth, MD, discusses how litifilimab’s 52-week AMETHYST findings inform treatment expectations and timely reassessment of persistent cutaneous lupus symptoms.
In an interview with Pharmacy Times, Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania and chief of dermatology at the Philadelphia VA Medical Center, discusses why meaningful improvement extends beyond skin clearance and how response timing affects patients with difficult-to-control disease.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
As psychedelic therapies advance through clinical development, pharmacists should prepare for potential roles in their safe, evidence-based integration into patient care.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Could Cemdisiran Keep Patients With Myasthenia Gravis Out of the Hospital?
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5